Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Roche Diagnostics

Develops, manufactures, and markets a wide range of in vitro diagnostic systems, instruments, reagents, and tests read more Featured Products: More products

Download Mobile App




Roche Introduces Digital Health Solutions Under Navify Brand

By LabMedica International staff writers
Posted on 08 Nov 2022

Roche (Basel, Switzerland) has announced that its digital health portfolio will now be available under the navify brand. The navify digital solutions help providers and patients 'navigate' and 'clarify' a wide range of touchpoints by activating insights that provide evidence on how to optimize operational processes and clinical decision making in healthcare.

Together, navify brings new ways to improve interoperability of digital infrastructure, use advanced analytics to deliver operational excellence, improved workflows, and patient-centric ways of working, and generate advanced medical insights that augment clinical decision support. The portfolio across Roche includes more than 30 digital solutions for labs, hospitals and patients worldwide and many key initiatives to advance digital transformation in healthcare. Several late stage pilots with customers and tech collaborators are underway for digital infrastructure (navify Core Integrator), operational excellence (navify Sample Tracking) and for medical insights (navify Screening for Cervical Cancer, navify Kidney Companion and navify Algorithm Suite).

With navify Marketplace, Roche connects labs and healthcare providers and third-party medtech and other companies to help bring innovations to healthcare. Several startups or companies are involved and more are joining: Smart4Diagnostics, imito (wound.app), decide Clinical Software (glucotab), Glytec, Precordior (CardioSignal), SteadySense (SteadyTemp), Deigma, TestCard, Etheclo, Tracie Healthcare Solutions and Binary Tech. Medial EarlySign, which develops AI-based clinical predictive analytics, is the latest to join, allowing for EarlySign ColonFlag to be accessible to labs and hospitals via the navify platform in the near future.

"Today we are using navify digital solutions, such as algorithms, and data science to deliver insights that are actionable in healthcare, building on three decades of software experience with diagnostics in laboratories," said Moritz Hartmann, Head of Roche Information Solutions. "We are creating open digital ecosystems with labs, hospitals and medtech companies to bring the latest innovations faster to society to better serve patients, and to support clinicians in providing care for patients. These activities support our strategy to deliver insights that drive personalised care."

Related Links:
Roche

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.